Company profile
Rebus Holdings, Inc.
OTC: RBSH · Healthcare · Biotechnology
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 26
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ workforce scale, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.0M
Employees
1
as of 2026-08-30
Market cap
$3.2k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$1.0M-$1.0M2022
Operating income-$664.0k-$664.0k2022
Total assets$5.0k$5.0k2022
Liabilities$5.2M$5.2M2022
Equity-$5.2M-$5.2M2022
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Rebus Holdings, Inc.’s financial profile?
Rebus Holdings, Inc. earned -$1.0M in FY2022 net income.
Peers · Healthcare
Cyclo3pss Corporation——Skylight Health Group Inc.——ER Urgent Care Holdings, Inc.——Corix Bioscience, Inc.——Southwestern Medical Solutions, Inc.——Longport, Inc.——Neighbors
Los Angeles →Key facts
CEORaul Silvestre
SectorHealthcare
IndustryBiotechnology
HeadquartersWestlake Village, CA
ExchangeOTC: RBSH
Employees1
IPO date2009-11-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.